Towards Healthcare
Ophthalmology Drugs Market to Promote USD 76.51 Bn by 2035

Ophthalmology Drugs Market Expands with Gene Therapy

Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing due to the rising geriatric population, and North America is dominating because of the rising research & development in drug development.

Content

  • Last Updated: 12 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The ophthalmology drugs market holds a valuation of USD 45.52 billion as of 2025, and will expand to USD 76.51 billion by 2035, achieving a CAGR of 5.33% between 2024 and 2034.

North America is currently leading the ophthalmology drugs market share by 42% due to rising clinical trials in ophthalmology.

The ophthalmology drugs market includes six segments such as by drug class, by indication, by molecule modality, by route of administration, by end-user channel, and by region.

Some key players include Regeneron Pharmaceuticals, Genentech Roche, Novartis, Bayer, Oxurion, etc.

Key trends include a growing geriatric population and, rise in eye diseases due to occupational hazards.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions